When and How to Treat Relapsed Multiple Myeloma
Nitya Nathwani1, Luca Bertamini2, Rahul Banerjee3
1Judy and Bernard Briskin Center for Multiple Myeloma Research, City of Hope, Duarte, CA.
Summary
Novel treatments for relapsed multiple myeloma offer improved responses and survival. Balancing treatment toxicities with patient-specific factors is crucial for effective management of early and late relapses.
Area of Science:
- Hematology
- Oncology
- Pharmacology
Background:
- The treatment of relapsed multiple myeloma has evolved significantly with the introduction of novel therapeutic agents.
- These advancements have improved response rates and survival outcomes, even in patients with advanced disease.
Purpose of the Study:
- To provide an overview of current treatment options for relapsed multiple myeloma.
- To discuss strategies for managing early and late relapsing disease.
- To explore the role of emerging immunotherapies in multiple myeloma treatment.
Main Methods:
- Literature review of recent advancements in multiple myeloma therapeutics.
- Analysis of treatment strategies considering disease biology, relapse patterns, and patient history.
- Discussion of novel agents and immune-based therapies.
Main Results:
- Numerous novel agents with diverse mechanisms of action are now available for relapsed multiple myeloma.
- These treatments demonstrate efficacy in improving responses and prolonging survival.
- Challenges include managing treatment toxicities and personalizing regimens.
Conclusions:
- The expanded treatment landscape for relapsed multiple myeloma necessitates careful consideration of individual patient factors.
- Emerging immune-based therapies represent a promising frontier in managing this complex malignancy.
- Optimizing treatment requires balancing efficacy, toxicity, and patient preferences.
More Related Videos
10:04Establishment of a Human Multiple Myeloma Xenograft Model in the Chicken to Study Tumor Growth, Invasion and Angiogenesis
Published on: May 1, 2015
13.2K
09:41An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
Published on: July 15, 2015
8.8K
Related Concept Videos
02:56Treatment Resistant Cancers
3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K
02:57Targeted Cancer Therapies
8.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.0K
02:49Cancer Therapies
8.9K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.9K
02:50Combination Therapies and Personalized Medicine
5.4K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.4K
01:27Tumor Immunotherapy
798
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
798
01:28Pulmonary Tuberculosis V
287
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
287